How to ensure reasonable profit of selected varieties in the collection? The National Health Service replied.

Medicine Network September 27th September 24th, the State Health Insurance Administration on the 13th National People's Congress three sessions on the national organization of centralized procurement of drugs related recommendations issued three consecutive replies, for the rational setting of the national centralized procurement catalog of low-cost base drug price limits, expand the scope of centralized procurement of national drugs, scientific and reasonable determination of centralized volume procurement entry criteria and other industry focus to give detailed responses.
three major aspects of opening up the space for pharmaceutical companies to reduce prices as a breakthrough to further deepen the reform of the medical and health system, the state-organized drug collection in 2018 "4 plus 7" pilot as the starting point, has been smoothly advanced to the third round.
The State Health Insurance Administration, in its briefing on the basic situation of national procurement, pointed out that when the implementation of the "4-plus-7" pilot expires in one year, the procurement volume of 25 selected drugs in the "4-plus-7" region is 2.4 times the agreed procurement volume, the procurement volume accounted for 78% of the procurement volume of generic drugs, 11 pilot cities in April this year completed the pilot after the expiration of the follow-up work.
And the "4 plus 7" national expansion and the second batch of collection has also been successfully implemented, the progress is better than expected, the first two batches of central research drugs and over-consistent evaluation of the use of generic drugs and other high-quality drugs from the original 50% to more than 90%.
But at the same time that the actual procurement volume of medical institutions has doubled directly to the winning drug companies to bring greater benefits, the pricing of the winning drug to break through the floor has also attracted the industry's heated discussion on the low price of drugs.
In the third batch of national mining, which ended at the end of August, according to a reporter from the Medical Economics Daily, the average decline of 191 selected products reached 53% compared with the most effective declared price, while the highest decline of hydrochloric acid gold tablets was more than 98%, but also produced three "one penny" varieties of Catopri, metformin and chlorine nitrogen flat.
For improving the centralized procurement rules for drugs to ensure reasonable profits, the State Health Insurance Administration said in its reply letter, "The centralized procurement of drugs organized by the state does not deliberately compress the reasonable profits of enterprises, the space for price reduction mainly comes from the following three aspects: First, through the volume of procurement 'ensure the use', enterprises have obtained the purchase volume commitment, no longer for drugs into the hospital and public relations, marketing costs greatly reduced."
the second is to 'ensure repayment' greatly shortens the medical institutions to settle drug payment cycle, reduce the cost of enterprise capital.
is the rapid expansion of the market sales of selected products, production costs are shared, the average cost is lower.
"The State Health Insurance Administration pointed out that the purpose of this top-level design of drug belt procurement is to improve the market-led drug price formation mechanism, the State Health Insurance Administration and other relevant organizations have always adhered to the principle of "voluntary participation, independent quotation, fair competition" of eligible enterprises, do not interfere with enterprises to participate in the collection and specific quotations, fully respect the will of enterprises, respect market rules.
to improve the efficiency of market competition and find prices more quickly and accurately by setting rules and organizing centralized procurement.
The practice of the first three rounds of volume procurement actually proves that it is an effective means to completely open up the enterprise price reduction space through reform and release the institutional cost, and its achievements in significantly reducing the inflated price of drugs and purifying the market circulation environment should be worthy of recognition by the industry.
to the proposal to set a reasonable price limit for low-cost drugs, the NHS admitted: "The most effective offer is the historical actual transaction price of a certain volume, not the government's."
In the second and third batch of national organization of centralized procurement of drugs, in order to balance the price level between regions, to avoid the selection price gap is too large, in the selected price clearly the price difference of the selected varieties not more than 1.8 times.
In order to prevent irrational competition behavior, the Joint Procurement Office specifically made it clear that when the reduction of the enterprise quotation is greater than or equal to 50% (based on the maximum effective declared price of the corresponding specifications in the Procurement Variety Catalog), even if the spread is more than 1.8 times can still be selected, which is actually in order to allow more enterprises to choose, to promote the protection of rational quotation measures.
"Reasonable determination of national drug collection standards each round of national drug collection criteria is undoubtedly the focus of attention of pharmaceutical companies, for "based on drug economics, scientific and reasonable determination of centralized volume procurement finalist standards, to ensure the safety of the people's drug use", the State Health Insurance Administration replied, "the core of this round of centralized drug procurement reform is to play a decisive role in the allocation of resources, reduce artificial pricing."
" According to the reply, the State Health Insurance Administration and other parties are currently through the enterprise's independent quotation, quality priority, value-oriented, demand-oriented, to ensure supply, fair competition and other six elements to ensure the orderly progress of the national drug collection work.
, the National Health Insurance Administration said that although the above-mentioned recommendations have some reference significance, but in the market competition is more adequate and can play a price discovery mechanism, play a decisive role in the market is a priority in the relevant work.
" Next, in accordance with the requirements of normalizing centralized drug procurement, we will work with relevant departments to explore the introduction of clinical efficacy evaluation and pharmaceutical economic evaluation into centralized procurement, so that centralized procurement more reflects clinical needs and market mechanism requirements.
" in the normal development of volume procurement, the expansion of the scope of national drug procurement will also be scheduled.
with regard to the identification of shortlisted varieties, the State Health Insurance Administration stated that it would adhere to the principle of "exhaustion" and include the varieties eligible for procurement in the procurement scope, on the premise of preventing monopoly and supply risks.
" will unswervingly promote reform, promote the normalization of centralized drug procurement by state organizations, constantly improve procurement rules, accelerate the promotion of centralized procurement of medicines and high-value medical supplies to become the leading mode of procurement of pharmaceuticals and high-value medical supplies, and expand the reform effect in accordance with the Opinions of the State Council of the CPC Central Committee on Deepening the Reform of the Medical Security System.
"it is worth noting that the exploration process of provincial and municipal procurement under national production has also been fully accelerated.
according to incomplete statistics, Fujian, Jiangxi and Shanxi provinces, Wuhan, Jinhua and Sanming and other 9 municipalities, have been carrying out drug belt procurement or the release of procurement programs.
In addition, according to industry news, Guangdong is expected to issue the provincial belt procurement and comprehensive network for comments draft, Guangxi second batch of group procurement has recently organized a related symposium, the selection of more than 300 band procurement varieties for group procurement, Chongqing Health Insurance Bureau has also carried out volume procurement-related research, is expected to cover more than 50 varieties, and Shaanxi-led inter-provincial alliance drug procurement is also on the road, Ningxia, Gansu and other places have been basically finalized.
at this stage, in the face of the country, local rolling drug belt procurement, pharmaceutical companies can only clear the rules under the premise of calm response.
.